What this study is
The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims related to the trial are to test the preliminary effectiveness of TECU compared to standard of care in reducing patient uncertainty and return ED visits and evaluate the adoption of TECU, exploring patient and clinician barriers and facilitators to TECU implementation.
What's being tested
- Targeted EHR-based Communication of Diagnostic Uncertainty (TECU)
Intervention · BEHAVIORAL
The Targeted EHR-based Communication about Uncertainty (TECU) strategy will be activated in the electronic health record (Epic) every time an ED clinician enters an uncertain diagnosis for a patient being discharged, and will notify the clinician to counsel the patient about uncertainty while additionally triggering automated 1) insertion and printing of the patient handout and 2) provision of a hyperlink for the clinician-facing checklist to guide the discharge conversation.
Study details
- Official title
- Targeted EHR-based Communication of Diagnostic Uncertainty (TECU) in the ED: An Effectiveness Implementation Trial
- Sponsor
- Thomas Jefferson University
- Conditions
- Diagnostic Uncertainty
- Enrolling
- 300 people
- Starts
- 2024-11-05
- Est. completion
- 2027-07-01
- Design
- Open-label, non-randomized, sequential groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Age 18 years or older
- English language speaking
- Assigned a symptom-based diagnosis in the EHR clinical impression
- Planned for discharge from the ED during the enrollment visit
- Able to complete follow up assessments in 2 and 30 days
- TECU best practice advisory (BPA) electronic health record alert activates during their discharge process
You can't join if
- Under the age of 18 years
- Non-English speaking
- Clinically unstable, psychologically impaired or intoxicated, or otherwise unable to provide informed consent as judged by research staff member
- Admitted to hospital
- Unable to complete follow up in 2 and 30 days
- Previously enrolled in this study (during a prior ED visit)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openThomas Jefferson University
Philadelphia, Pennsylvania, United States
- Amanda MB Doty, MS · Contact2155034619amanda.doty@jefferson.edu
- Philip Watts · Contact215-520-7595Phillip.Watts@jefferson.edu
- Kristin L Rising, MD, MS · Principal investigator
- Danielle McCarthy, MD, MS · Principal investigator
- Sara Malone, LCSW, PhD · Sub-investigator
- Dimitrios Papanagnou, MD PhD · Sub-investigator
- Rahul Yadav, MD · Sub-investigator
- Benjamin Leiby, PhD · Sub-investigator
Recruiting
Study team
Sponsor
Thomas Jefferson University
Study ID 1R18HS029791-01
Principal investigator
Kristin L Rising, MD, MS
Thomas Jefferson University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.